These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31422113)

  • 1. Strategies of targeting pathological stroma for enhanced antitumor therapies.
    Zhu Y; Yu F; Tan Y; Yuan H; Hu F
    Pharmacol Res; 2019 Oct; 148():104401. PubMed ID: 31422113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
    Guo J; Zeng H; Chen Y
    Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversing activity of cancer associated fibroblast for staged glycolipid micelles against internal breast tumor cells.
    Zhu Y; Yu F; Tan Y; Hong Y; Meng T; Liu Y; Dai S; Qiu G; Yuan H; Hu F
    Theranostics; 2019; 9(23):6764-6779. PubMed ID: 31660067
    [No Abstract]   [Full Text] [Related]  

  • 4. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
    Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
    Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
    Xue X; Wang X; Pang M; Yu L; Qian J; Li X; Tian M; Lu C; Xiao C; Liu Y
    J Nanobiotechnology; 2024 Apr; 22(1):196. PubMed ID: 38644492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflections on depletion of tumor stroma in pancreatic cancer.
    Wang WQ; Liu L; Xu JZ; Yu XJ
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):267-272. PubMed ID: 30738097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.
    Li W; Little N; Park J; Foster CA; Chen J; Lu J
    Mol Pharm; 2021 Aug; 18(8):2889-2905. PubMed ID: 34260250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
    Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity and Biology of Cancer-Associated Fibroblasts.
    Biffi G; Tuveson DA
    Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment.
    Anajafi S; Paryan M; Khoshnazar A; Soleimani M; Mohammadi-Yeganeh S
    Endocr Metab Immune Disord Drug Targets; 2024; 24(3):333-347. PubMed ID: 37612874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
    Kanzaki R; Pietras K
    Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts.
    Kovács D; Igaz N; Marton A; Rónavári A; Bélteky P; Bodai L; Spengler G; Tiszlavicz L; Rázga Z; Hegyi P; Vizler C; Boros IM; Kónya Z; Kiricsi M
    J Nanobiotechnology; 2020 Jan; 18(1):18. PubMed ID: 31964403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer.
    Zhou Y; Ma Y; Sheng J; Ma Y; Ding J; Zhou W
    Mol Pharm; 2024 Aug; 21(8):3764-3776. PubMed ID: 39049481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies.
    Darvishi B; Majidzadeh-A K; Ghadirian R; Mosayebzadeh M; Farahmand L
    Life Sci; 2019 Jan; 217():34-40. PubMed ID: 30472294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
    Huang C; Xu J; Li Z
    Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):267-273. PubMed ID: 32316714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of cancer-associated fibroblasts and their microenvironment in post-chemotherapy recurrence.
    Ishii G; Ishii T
    Hum Cell; 2020 Oct; 33(4):938-945. PubMed ID: 32852669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.